AM

Akshat Mehrotra

Active Director Director DIN 10719892
DIN 10719892 First appointment Jul 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Akshat Mehrotra

Data last updated:

Akshat Mehrotra is a Director at Siddh Foundation For Medical Relief (since 2024).

DIN 10719892
Primary Designation Director
First Appointment 25 Jul 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Siddh Foundation For Medical Relief U86201UP2024NPL206879
Director25 Jul 20242024Active

Board colleagues of Akshat Mehrotra

NameDINCompanyDesignation
Anika Mehrotra10719891Siddh Foundation For Medical ReliefDirector

Directorship timeline

Open interactive timeline →
Siddh Foundation For Medical Relief
Premium access

Shareholding and investment profile for Akshat Mehrotra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Akshat Mehrotra

Akshat Mehrotra currently holds 1 directorship: Siddh Foundation For Medical Relief (Director, since 25 Jul 2024).

Akshat Mehrotra was first appointed on 25 Jul 2024 as Director at Siddh Foundation For Medical Relief.

The current boards of Akshat Mehrotra's companies include Anika Mehrotra (Siddh Foundation For Medical Relief).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available